| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K09344309 |
| PharmacoGx | BRD-K09344309 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD2BP2 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | CACNA1G | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | FRS2 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | PRPF19 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | EBLN1 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | PSMA4 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | FEZF2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | C10orf71 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | ATG7 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | TPR | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
